Inventor · disambiguated record
Ashvinikumar V. Gavai
Also filed as: GAVAI ASHVINIKUMAR V
59 granted patents·18 pending applications·854 citations·filing 1994–2022
98Inventor score
Files withBRISTOL MYERS SQUIBB CO58INNATE TUMOR IMMUNITY INC10FINK BRIAN E3CHEN PING1GAVAI ASHVINIKUMAR V1
Top patents by PatentIndex Score
77 records- 0198US5770615ACatecholamine surrogates useful as β3 agonistsBRISTOL MYERS SQUIBB CO·Filed 1997·Granted Jun 23, 1998·254 cites·23 claims
- 0297US9458156B2Tricyclic compounds as anticancer agentsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Oct 4, 2016·25 cites·3 claims
- 0396US5776983ACatecholamine surrogates useful as β3 agonistsBRISTOL MYERS SQUIBB CO·Filed 1994·Granted Jul 7, 1998·300 cites·14 claims
- 0494US9273057B2Imidazotriazinecarbonitriles useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Mar 1, 2016·29 cites·15 claims
- 0594US6916815B2C-6 modified indazolylpyrrolotriazinesBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Jul 12, 2005·55 cites·10 claims
- 0692US9273014B2Bis(fluoroalkyl)-1,4-benzodiazepinone compounds and prodrugs thereofBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Mar 1, 2016·14 cites·11 claims
- 0790US8629136B2Bisfluoroalkyl-1,4-benzodiazepinone compoundsGAVAI ASHVINIKUMAR V·Filed 2012·Granted Jan 14, 2014·25 cites·19 claims
- 0890US7148220B2C-6 modified indazolylpyrrolotriazinesBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Dec 12, 2006·13 cites·3 claims
- 0989US8252795B2Imidazopyridazinecarbonitriles useful as kinase inhibitorsFINK BRIAN E·Filed 2009·Granted Aug 28, 2012·19 cites·11 claims
- 1089US7297695B2Pyrrolotriazine compounds as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Nov 20, 2007·9 cites·4 claims
- 1188US8822454B2Bisfluoroalkyl-1,4-benzodiazepinone compoundsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Sep 2, 2014·9 cites·6 claims
- 1288US7151176B2Pyrrolotriazine compoundsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Dec 19, 2006·12 cites·5 claims
- 1387US11344543B2NLRP3 modulatorsINNATE TUMOR IMMUNITY INC·Filed 2018·Granted May 31, 2022·2 cites·25 claims
- 1486US8999918B2Bis(fluoroalkyl)-1,4-benzodiazepinone compounds and prodrugs thereofBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Apr 7, 2015·9 cites·19 claims
- 1585US7102003B2Pyrrolotriazine compoundsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Sep 5, 2006·11 cites·5 claims
- 1684US7442700B2Pyrrolotriazine compounds useful as kinase inhibitors and methods of treating kinase-associated conditions therewithBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Oct 28, 2008·5 cites·20 claims
- 1783US9273075B2Prodrugs of 1,4-benzodiazepinone compoundsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Mar 1, 2016·4 cites·9 claims
- 1881US9133139B2Fluoroalkyl-1,4-benzodiazepinone compoundsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Sep 15, 2015·2 cites·10 claims
- 1981US7417040B2Fused tricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3BRISTOL MYERS SQUIBB CO·Filed 2005·Granted Aug 26, 2008·3 cites·13 claims
- 2079US9556178B2Imidazotriazinecarbonitriles useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Jan 31, 2017·3 cites·7 claims
- 2179US9492460B2Carbazole compounds useful as bromodomain inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Nov 15, 2016·4 cites·15 claims
- 2279US8940736B2Imidazotriazinecarbonitriles useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Jan 27, 2015·3 cites·19 claims
- 2378US10053454B2Carbazole compounds useful as bromodomain inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Aug 21, 2018·3 cites·5 claims
- 2478US7378426B2Fused heterotricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3BRISTOL MYERS SQUIBB CO·Filed 2005·Granted May 27, 2008·2 cites·30 claims
- 2578US7141571B2Pyrrolotriazine compounds as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Nov 28, 2006·8 cites·4 claims
- 2677US8791257B2Substituted pyrrolotriazines as protein kinase inhibitorsMARKWALDER JAY A·Filed 2011·Granted Jul 29, 2014·6 cites·13 claims
- 2777US7064203B2Di-substituted pyrrolotriazine compoundsBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Jun 20, 2006·9 cites·6 claims
- 2876US7846931B2Pyrrolotriazine compounds as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2008·Granted Dec 7, 2010·1 cites·1 claims
- 2976US7102001B2Process for preparing pyrrolotriazineBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Sep 5, 2006·9 cites·6 claims
- 3074US9751879B2Tricyclic compounds as anticancer agentsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Sep 5, 2017·1 cites·13 claims
- 3173US12171756B2NLRP3 modulatorsINNATE TUMOR IMMUNITY INC·Filed 2022·Granted Dec 24, 2024·0 cites·10 claims
- 3270US7105537B22-substituted cyclic amines as calcium sensing receptor modulatorsBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Sep 12, 2006·4 cites·7 claims
- 3369US8389527B2Substituted imidazopyridazines useful as kinase inhibitorsFINK BRIAN E·Filed 2009·Granted Mar 5, 2013·1 cites·12 claims
- 3465US2014357605A1Bis(fluoroalkyl)-1,4-benzodiazepinone compoundsBRISTOL MYERS SQUIBB CO·Filed 2014·Application pending·0 cites
- 3564US10112941B2Tricyclic compounds as anticancer agentsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Oct 30, 2018·0 cites·3 claims
- 3663US2009062288A1Pyrrolotriazine compounds useful as kinase inhibitors and methods of treating kinase-associated conditions therewithMASTALERZ HAROLD·Filed 2008·Application pending·0 cites
- 3757US9371328B2Imidazopyridazinecarbonitriles useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Jun 21, 2016·0 cites·8 claims
- 3856US2016060232A1Bis(fluoroalkyl)-1,4-benzodiazepinone compoundsBRISTOL MYERS SQUIBB CO·Filed 2015·Application pending·0 cites
- 3955US12485123B21H-pyrazolo[4,3-d]pyrimidine compounds as toll-like receptor 7 (TLR7) agonistsBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Dec 2, 2025·0 cites·10 claims
- 4055US12201627B2NLRP3 modulatorsINNATE TUMOR IMMUNITY INC·Filed 2019·Granted Jan 21, 2025·0 cites·17 claims
- 4155US2015284342A1Bis(fluoroalkyl)-1,4-benzodiazepinone compoundsBRISTOL MYERS SQUIBB CO·Filed 2015·Application pending·0 cites
- 4254US12391675B2NLRP3 modulatorsINNATE TUMOR IMMUNITY INC·Filed 2020·Granted Aug 19, 2025·0 cites·13 claims
- 4354US9187434B2Substituted 1,5-benzodiazepinones compoundsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Nov 17, 2015·0 cites·9 claims
- 4454US9133126B2Fluoroalkyl dibenzoazepinone compoundsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Sep 15, 2015·0 cites·8 claims
- 4554US2011039838A1Pyrrolotriazine compounds as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2010·Application pending·0 cites
- 4653US9249157B2Tricyclic heterocycle compoundsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Feb 2, 2016·0 cites·8 claims
- 4753US2023041738A11H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTSBRISTOL MYERS SQUIBB CO·Filed 2021·Application pending·0 cites
- 4853US2023122249A11H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTSBRISTOL MYERS SQUIBB CO·Filed 2021·Application pending·0 cites
- 4953US2023140430A11H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTSBRISTOL MYERS SQUIBB CO·Filed 2021·Application pending·0 cites
- 5053US2023348468A11H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTSBRISTOL MYERS SQUIBB CO·Filed 2021·Application pending·0 cites
Showing the top 50 of 77 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Ashvinikumar V. Gavai files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →